CNNMoney.com
Companies Economy International Corrections Pre-market trading After-hours trading Winners/losers/actives Bonds Currencies Commodities Money Magazine Retirement Mutual Funds Taxes Ask the Expert Money 101 Autos Loan Center Best Places to Live Calculators Mortgage Rates Personal tech Big Tech blog Techland blog Sectors and stocks Fortune 500 techs Tech Talk 100 best places to launch Ultimate resource guide Small biz makeovers FSB 100 Ask & Answer Fortune 500 Technology Investing Management Rankings Main Create portfolio Edit portfolio Create Alerts Edit Alerts
Alcon Inc &
Novartis AG
Update Date: 07/13/08
Date Announced: 04/07/08
Value (million $USD): 10.55 billion U.S. Dollar
Status: Completed
TRANSACTION DETAILS
Date Announced04/07/08
Date Originally Announced04/07/08
FormatAcq. Part. Int.Acquisition techniquesPrivately Negotiated Purc
AttitudeFriendlyAgencyUnspecified Regulatory Auth.
Value10.55 billion U.S. DollarAdvisor Feesn/a
SYNOPSIS
US - Novartis AG (NA) acquired a 25% stake, or 73.666 mil common shares, in Alcon Inc (AI), a manufacturer and wholesaler of pharmaceuticals, surgical equipment and devices, and contact lens care and other vision care products, from Nestle SA, for $143.18 in cash per share, or a total value of $10.547 bil, in a privately negotiated transaction. The transaction had been subject to regulatory approval. Concurrently, NA was granted an option to raise its interest to 77% from 25% by acquiring a 52% interest, or 153.225 mil common shares, in AI.
TARGET
NameAlcon Inc (ACL)
IndustriesSurgical and medical instruments and apparatus; Pharmaceutical preparations; Medical, dental, and hospital equipment & supplies
CityFort Worth
StateTX
NationUnited States
Incorporated inn/a
Public StatusPublic
Business DescriptionAlcon Inc, located in Fort Worth, Texas, manufactures and wholesales pharmaceuticals, surgical equipment and devices, and contact lens care and other vision care products that treat conditions of the eye. The company was founded in 1945.
AdvisorsCredit Suisse Group; Citi
Target Sales5.94 billion U.S. Dollar
ACQUIROR
NameNovartis AG (Zurich : NOVZN)
IndustriesOphthalmic goods; Dry, condensed, and evaporated dairy products; Canned specialties; Offices of holding companies, nec
CityBasel
Staten/a
NationSwitzerland
Incorporated inn/a
Public StatusPublic
Business DescriptionNovartis AG, headquartered in Basel, Switzerland, manufactures pharmaceuticals including self-medications and non-prescription drugs. It also manufactures optical and ophthalmic products including contact lenses. The company produces nutritional products including baby formula and baby canned food and serves as a holding company. It was founded in 1996.
AdvisorsGoldman Sachs & Co
Acquiror Sales44.74 billion U.S. Dollar
44.49 billion Swiss Franc
© 2008 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy
Copyright © 2008 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. All Times are ET.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Hemscott.
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.